Given the extensive degradation activity of MMP-13 and its increased presence in inflammatory bone diseases, a better understanding of MMP-13 expression and regulation may lead to therapeutic strategies aimed at inhibiting bone destruction. The gene discussed is MMP13; the disease is bone inflammation disease.